“…Under the intraperitoneal LEDZ administration in the stage of chronic BCG granulomatosis (6 months after infection with BCG vaccine, LEDZ administration for 3 months), the lung contents of hyaluronan, perlecan, peptide-bound hydroxyproline, and protein-bound hydroxyproline decreased, but the content of free hydroxyproline increased (Figure 1D), indicating increased degradation of collagens and suppression of their synthesis [123,130]. The introduction of LEDZ at this stage of BCG granulomatosis led to a decrease in the activity of MMPs and specific and non-specific inhibitors (TIMP-1, TIMP-2, and α2-MG), which also implies a decrease in the activity of destructive-inflammatory potential [122]. The combined decrease in MMPs and α2-MG activity, level in TIMP-1 and TIMP-2 indicates the suppression of protease, antiprotease activity, and inflammatory response due to the influence of LEDZ.…”